- Home
- LGCB vs BCLI Comparison
LGCB vs BCLI Comparison
Compare LGCB & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- BCLI
- Stock Information
- Founded
- LGCB 2011
- BCLI 2000
- Country
- LGCB Japan
- BCLI United States
- Employees
- LGCB N/A
- BCLI N/A
- Industry
- LGCB
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LGCB
- BCLI Health Care
- Exchange
- LGCB Nasdaq
- BCLI Nasdaq
- Market Cap
- LGCB 5.9M
- BCLI 6.4M
- IPO Year
- LGCB 2023
- BCLI N/A
- Fundamental
- Price
- LGCB $0.23
- BCLI $1.25
- Analyst Decision
- LGCB
- BCLI Strong Buy
- Analyst Count
- LGCB 0
- BCLI 1
- Target Price
- LGCB N/A
- BCLI $30.00
- AVG Volume (30 Days)
- LGCB 1.2M
- BCLI 120.5K
- Earning Date
- LGCB 11-29-2024
- BCLI 11-14-2024
- Dividend Yield
- LGCB N/A
- BCLI N/A
- EPS Growth
- LGCB N/A
- BCLI N/A
- EPS
- LGCB N/A
- BCLI N/A
- Revenue
- LGCB $8,500,375.00
- BCLI N/A
- Revenue This Year
- LGCB N/A
- BCLI N/A
- Revenue Next Year
- LGCB N/A
- BCLI N/A
- P/E Ratio
- LGCB N/A
- BCLI N/A
- Revenue Growth
- LGCB N/A
- BCLI N/A
- 52 Week Low
- LGCB $0.20
- BCLI $1.05
- 52 Week High
- LGCB $5.71
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- LGCB 34.41
- BCLI 27.21
- Support Level
- LGCB $0.21
- BCLI $1.05
- Resistance Level
- LGCB $0.24
- BCLI $1.30
- Average True Range (ATR)
- LGCB 0.04
- BCLI 0.18
- MACD
- LGCB 0.02
- BCLI 0.04
- Stochastic Oscillator
- LGCB 21.45
- BCLI 24.69
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides global e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, global store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.